SCHEMBL5118577

SCHEMBL5118577

CC(C)C(=O)Nc1cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)cc(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.41
RHOC P08134 1/20 0.40
RHOA P61586 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CLPP Q16740 1/20 0.39
MRGPRX4 Q96LA9 9/20 0.39
SENP5 Q96HI0 1/20 0.38
SENP2 Q9HC62 1/20 0.38
SENP1 Q9P0U3 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
JUN P05412 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722472 0.96 THRB (0.41) SCN9ARHOCRHOASMN1; SMN2CLPP
SCHEMBL5111593 0.91 THRA (0.42) SCN9ARHOCRHOASMN1; SMN2CLPP
SCHEMBL4923555 0.89 MRGPRX4 (0.41) RHOCRHOAMRGPRX4
SCHEMBL5104851 0.89 RHOC (0.42) RHOCRHOAMRGPRX4JUNNFKB1
SCHEMBL5722474 0.88 SCN9A (0.39) SCN9ARHOCRHOASMN1; SMN2CLPP
SCHEMBL5103298 0.88 RHOC (0.45) RHOCRHOAMRGPRX4SENP5SENP2
SCHEMBL5110128 0.87 SENP5 (0.40) SMN1; SMN2SENP5SENP2SENP1ALDH1A1
SCHEMBL4932213 0.87 MRGPRX4 (0.43) RHOCRHOAMRGPRX4MEN1KMT2A
SCHEMBL5104457 0.87 SENP5 (0.41) SMN1; SMN2MRGPRX4SENP5SENP2SENP1
SCHEMBL5117805 0.86 SENP5 (0.40) SMN1; SMN2SENP5SENP2SENP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA SCN9A 1472/4885RHOC 1411/4885RHOA 1679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.